Back to results
US 9,872,829 B2Granted
Core sheath drug delivery devices
AssigneeChemo Research, S.L.
InventorsAndrew Loxley, Mark Mitchnick, Gonzalo Hernández Herrero, Celestino Ronchi
Life of this patent
Estimating the term…
Abstract
It relates to a device comprising (a) a core comprising polyurethane; (b) a sheath comprising ethylene vinyl acetate copolymer, said sheath substantially or completely surrounding said core; and (c) one or more active pharmaceutical ingredients dissolved or dispersed in said core and/or said sheath; and to a process for its preparation.
Claims24
A device comprising:
- (a) a core, said core comprising at least 90% of polyurethane,
- wherein the polyurethane is selected from aliphatic polyether-based thermoplastic polyurethanes, aliphatic hydrophilic polyether-based thermoplastic polyurethanes, aromatic polyether-based thermoplastic polyurethanes, aliphatic polycarbonate-based thermoplastic polyurethanes, aromatic polycarbonate-based thermoplastic polyurethanes, aromatic polyether based polyurethane elastomers, thermoplastic polyether poly(urethanes), thermoplastic silicone polyether polyurethanes, thermoplastic silicone polycarbonate polyurethanes and hydrophilic thermoplastic polyurethane elastomers;
- (b) a sheath, said sheath substantially or completely surrounding said core, said sheath comprising from 50 to 100% of ethylene vinyl acetate copolymer,
- wherein the ethylene vinyl acetate copolymer has a vinyl acetate content from 1 to 50% w/w, and,
- wherein said sheath has a thickness from 5 to 500 μm;
- and
- (c) one or more active pharmaceutical ingredients dissolved or dispersed in said core and/or said sheath;
- wherein the one or more active pharmaceutical ingredients are eluted at or near zero order.
5 more elements
Dependencies are inferred from the claim text.